Atyr Pharma Inc (NASDAQ:ATYR) does about 1.63M shares in volume on a normal day but saw 2831276 shares change hands in the recent trading day. The company now has a market cap of 457.48M USD. Its current market price is $5.14, marking a decrease of -6.20% compared to the previous close of $5.48. The 52 week high reached by this stock is $5.98 whilst the lowest price level in 52 weeks is $1.42.
The consensus objective for the share price is $18.55, suggesting that the stock has a potential upside of 72.29% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 18, 2025 when Leerink Partners initiated the stock to “Outperform” and issued a price target of $16. Wells Fargo initiated its price target at $17.
The current price level is 7.99%, 34.22%, and 56.85% away from its SMA20, SMA50, and SMA200 respectively, with the ATYR price moving below the 50-day SMA on current market day. Atyr Pharma Inc (ATYR) stock is down -6.55% over the week and 57.19% over the past month. Its price is 41.99% year-to-date and 177.84% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.18 and -0.61 for whole year. Expected sales for next quarter are $1.09M, which analysts say will come at $6.55M for the current fiscal year and next year at $24.23M.
To reach the target analysts have set, the stock logically needs to grow 72.29 percent from here.
The company has a return on investment of -73.10% and return on equity of -79.51%. The beta has a value of 0.89. Price to book ratio is 6.10.
